Form 4: Septerna Inc. Director Bernard Coulie Acquires Stock Options

Septerna, Inc. director Bernard Coulie has acquired 15,000 stock options, with vesting tied to service and the company's next annual meeting.

Summary

• Bernard Coulie, a Director at Septerna, Inc., was granted 15,000 stock options on June 26, 2026.
• These options have an exercise price of $37.34 and an expiration date of June 25, 2036.
• The underlying shares are 15,000 shares of Common Stock.
• The options vest in full on the earlier of June 26, 2027, or the date of the Issuer's next annual meeting of stockholders, contingent upon Coulie's continued service.
• A substitute Power of Attorney was filed on February 10, 2026, appointing Gil M. Labrucherie and Mark A. Wilson as substitute attorneys-in-fact for various individuals, including Bernard Coulie, for SEC filings.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard grant of stock options to a director with a typical vesting schedule, providing no immediate indication of significant positive or negative developments for the company.

Positives

• Director Bernard Coulie's acquisition of stock options indicates a commitment to the company's future performance.
• The vesting schedule is tied to continued service, aligning the director's incentives with the company's long-term success.

Risks

• The value of the stock options is subject to market fluctuations and the company's stock performance.
• Vesting is contingent on continued service, meaning any departure before the vesting date would result in forfeiture of the unvested options.

Future Outlook

The stock options acquired by Bernard Coulie are exercisable until June 25, 2036, with full vesting expected by June 26, 2027, or the next annual meeting, subject to continued service.

Industry Context

StockSavvy.ai notes that the filing of a Form 4 by a director is a routine disclosure of changes in beneficial ownership, often involving the grant or exercise of stock options, which is a common form of executive compensation in the biotechnology and technology sectors where Septerna Inc. operates.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of options to a director aligns management incentives with shareholder interests, potentially leading to increased focus on stock performance.
• Employees: While not directly impacting employees, such grants are part of the broader compensation structure for executives and directors within the company.
• Management: Bernard Coulie benefits from the potential future value of the stock options, contingent on his continued service and company performance.

Next Steps

• Bernard Coulie's continued service to Septerna, Inc. through the vesting dates.
• Potential exercise of stock options upon vesting and subject to market conditions.
• Future SEC filings to report any further changes in beneficial ownership.

Key Dates

Keywords

Form 4, SEC Filing, Stock Options, Insider Trading, Septerna Inc., SEPN, Bernard Coulie, Director, Beneficial Ownership, Vesting Schedule, Power of Attorney